Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.

Norlén O, Stålberg P, Öberg K, Eriksson J, Hedberg J, Hessman O, Janson ET, Hellman P, Åkerström G.

World J Surg. 2012 Jun;36(6):1419-31. doi: 10.1007/s00268-011-1296-z.

PMID:
21984144
2.

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.

Hellman P, Lundström T, Ohrvall U, Eriksson B, Skogseid B, Oberg K, Tiensuu Janson E, Akerström G.

World J Surg. 2002 Aug;26(8):991-7.

PMID:
12016480
3.

Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.

Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J.

Cancer. 2004 Aug 1;101(3):518-26.

4.

Indication for liver transplantation in young patients with small intestinal NETs is rare?

Norlén O, Daskalakis K, Öberg K, Åkerström G, Stålberg P, Hellman P.

World J Surg. 2014 Mar;38(3):742-7.

PMID:
24233660
5.

Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.

Bertani E, Falconi M, Grana C, Botteri E, Chiappa A, Misitano P, Spada F, Ravizza D, Bazolli B, Fazio N.

Int J Surg. 2015 Aug;20:58-64. doi: 10.1016/j.ijsu.2015.06.019.

PMID:
26074290
6.

Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study.

Le Roux C, Lombard-Bohas C, Delmas C, Dominguez-Tinajero S, Ruszniewski P, Samalin E, Raoul JL, Renard P, Baudin E, Robaskiewicz M, Mitry E, Cadiot G; Groupe d'étude des Tumeurs Endocrines (GTE)..

Dig Liver Dis. 2011 Oct;43(10):828-33. doi: 10.1016/j.dld.2011.04.021.

PMID:
21641888
7.

Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.

Norlén O, Edfeldt K, Akerstrom G, Westin G, Hellman P, Bjorklund P, Stalberg P.

Surgery. 2014 Dec;156(6):1512-21; discussion 1521-2. doi: 10.1016/j.surg.2014.08.090.

PMID:
25456945
8.

Small intestinal neuroendocrine tumors: prognostic factors and survival.

Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E.

Scand J Gastroenterol. 2009;44(9):1084-91. doi: 10.1080/00365520903082432.

PMID:
19572232
9.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
10.

[Indications and operative procedures for neuroendocrine liver metastases].

Musholt TJ, Lang H.

Chirurg. 2009 Feb;80(2):113-21. doi: 10.1007/s00104-008-1614-7. Review. German.

PMID:
19212693
11.

Role of imaging in the preoperative staging of small bowel neuroendocrine tumors.

Chambers AJ, Pasieka JL, Dixon E, Rorstad O.

J Am Coll Surg. 2010 Nov;211(5):620-7. doi: 10.1016/j.jamcollsurg.2010.07.016.

PMID:
21035044
12.

Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.

Zhu GL, Sun Z, Wang ZN, Xu YY, Huang BJ, Xu Y, Zhu Z, Xu HM.

J Surg Oncol. 2012 Jun 15;105(8):786-92. doi: 10.1002/jso.22149.

PMID:
22105768
13.

Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.

Saxena A, Chua TC, Zhao J, Morris DL.

J Surg Oncol. 2012 Mar 15;105(4):342-50. doi: 10.1002/jso.22114.

PMID:
22006355
14.

A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.

Modlin IM, Gustafsson BI, Pavel M, Svejda B, Lawrence B, Kidd M.

Neuroendocrinology. 2010;92(3):143-57. doi: 10.1159/000319784.

15.

[Tumors of the lower gastrointestinal tract : Indication and extent of lymph node dissection].

Merkel S, Weber K, Perrakis A, Göhl J, Hohenberger W.

Chirurg. 2010 Feb;81(2):117-22; 124-26. doi: 10.1007/s00104-009-1814-9. German.

PMID:
20146049
16.

Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients.

Dong XD, Carr BI.

Med Oncol. 2011 Dec;28 Suppl 1:S286-90. doi: 10.1007/s12032-010-9750-6.

PMID:
21107755
17.

[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].

Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C.

Chir Ital. 2005 Sep-Oct;57(5):555-70. Italian.

PMID:
16241086
18.

Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.

Schomas DA, Miller RC, Donohue JH, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Gunderson LL.

Ann Surg. 2009 Apr;249(4):588-95. doi: 10.1097/SLA.0b013e31819ec7e3.

PMID:
19300231
19.

Hepatic neuroendocrine metastases: does intervention alter outcomes?

Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, Blumgart LH.

J Am Coll Surg. 2000 Apr;190(4):432-45.

PMID:
10757381
20.

[Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].

Chen YF, Chen FJ, Yang AK, Zeng ZY, Song M, Li QL.

Ai Zheng. 2004 May;23(5):584-8. Chinese.

PMID:
15142460
Items per page

Supplemental Content

Support Center